Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
ClinicalTrials.gov study NCT01059630. IPD Sharing: Not stated. Countries: 14. Publications: 4.
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
ClinicalTrials.gov study NCT02626455. IPD Sharing: NO. Countries: 35. Publications: 2.
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01316523. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00764517. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01200758. IPD Sharing: Not stated. Countries: 30. Publications: 4.
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT01780662. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03209973. IPD Sharing: YES. Countries: 1. Publications: 3.
A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01796171. IPD Sharing: Not stated. Countries: 24. Publications: 6.
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00389818. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT01660451. IPD Sharing: NO. Countries: 25. Publications: 3.
Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03114683. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00274924. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT01193842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma
ClinicalTrials.gov study NCT00343564. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
ClinicalTrials.gov study NCT00322842. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
ClinicalTrials.gov study NCT01200589. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Therapy for Pediatric Hodgkin Lymphoma
ClinicalTrials.gov study NCT00145600. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
ClinicalTrials.gov study NCT01938001. IPD Sharing: Not stated. Countries: 17. Publications: 2.
Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03010358. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
ClinicalTrials.gov study NCT02758717. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.